Document:

Exhibit 4.5

 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”), AND MAY NOT BE SOLD, TRANSFERRED,
ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE
IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE COMPANY STATING THAT
SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT.

 

	Warrant No. CW-	Number of Series C Preferred Stock: 

Date of Issuance:

 

EDGE THERAPEUTICS, INC.

 

Preferred Stock Warrant

 

Edge Therapeutics,
Inc. (the “Company”), for value received, hereby certifies that Maxim Partners LLC, or its registered assigns
(the “Registered Holder”), is entitled, subject to the terms of this Series C Preferred Stock Warrant (the “Warrant”)
set forth below, to purchase from the Company, at any time after , 2013 (the “Commencement Date”) and
on or before the later of (i) , 2018 or five (5) years from the Final Closing Date, as defined in the Placement Agent Agreement,
dated March 18, 2013, by and between the Company and the Registered Holder (the “Expiration Date”), up to (
) shares of Series C Preferred Stock of the Company (the “Warrant Stock”), par value $0.00033 per share (the
“Preferred Stock”), at a per share exercise price (the “Exercise Price”) equal to $4.235
per share (subject to adjustment as set forth in Section 2).

 

1.Exercise.

 

(a)Method of Exercise.
This Warrant may be exercised by the Registered Holder, in whole or in part, by delivering the form appended hereto as Exhibit A
duly executed by such Registered Holder (the “Exercise Notice”), at the principal office of the Company, or
at such other office or agency as the Company may designate in writing prior to the date of such exercise, accompanied by payment
in full of the Exercise Price payable with respect to the number of shares of Warrant Stock purchased upon such exercise. The Exercise
Price must be paid by cash, check or wire transfer in immediately available funds for the Warrant Stock being purchased by the
Registered Holder, except as provided in Section 1(c).

 

(b)Effective
Time of Exercise. Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of
business on the day on which the Exercise Notice has been delivered to the Company (the “Exercise Date”) as
provided in this Section 1. At such time, the person or persons in whose name or names any certificates for Warrant Stock shall
be issuable upon such exercise as provided in Section 1(d) below shall be deemed to have become the holder or holders of record
of the Warrant Stock represented by such certificates.

 

    	 

    	 

    

(c)Cashless
Exercise. Notwithstanding any provisions herein to the contrary, in lieu of exercising this Warrant in the manner set forth
in Section 1(a), the Registered Holder may elect to exercise this Warrant, or a portion hereof, and to pay for the Warrant Stock
by way of cashless exercise (a “Cashless Exercise”). If the Registered Holder wishes to effect a cashless exercise,
the Registered Holder shall deliver the Exercise Notice duly executed by such Registered Holder or by such Registered Holder’s
duly authorized attorney, at the principal office of the Company, or at such other office or agency as the Company may designate
in writing prior to the date of such exercise, in which event the Company shall issue to the Registered Holder the number of shares
of Warrant Stock computed according to the following equation:

 

X = Y * (A-B)

     A

      where

 

; where

 

X = the number of shares
of Warrant Stock to be issued to the Registered Holder.

 

Y = the Warrant Stock
purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant Stock being
exercised.

 

A = the Fair Market Value
(defined below) of one share of Preferred Stock on the Exercise Date.

 

B = the Exercise Price
(as adjusted pursuant to the provisions of this Warrant).

 

For purposes of this
Section 1(c), the “Fair Market Value” of one share of Preferred Stock on the Exercise Date shall have one of the following
meanings:

 

(1)the Fair Market
Value shall be determined as follows for the Preferred Stock by calculating the number of shares of Common Stock, par value $0.00033
(the “Common Stock”) the holder would have received upon conversion of the Preferred Stock and multiplying such
converted shares by the Fair Market Value of the Common Stock, which shall be determined by:

 

(a) if the Common
Stock is traded on a national securities exchange, the Fair Market Value shall be deemed to be the average of the Closing Prices
over a five trading day period ending on the Exercise Date. For the purposes of this Warrant, “Closing Price” means
the final price at which one share of Common Stock is traded during any trading day; or

 

(b) if the Common
Stock is traded over-the-counter, the Fair Market Value shall be deemed to be the average of the Closing Price over the five day
period ending on the Exercise Date. If no Closing Price is reported for the Common Stock, the average of the bid and ask prices
for the Common Stock as reported in the over the counter market will be used instead of the Closing Price.

 

(2)if neither (1)(a)
nor (b) is applicable, the Fair Market Value shall be at the commercially reasonable price per share which the Company could obtain
on the Exercise Date from a willing buyer for shares of Preferred Stock sold by the Company, from authorized but unissued shares,
as determined in good faith by the Company’s Board of Directors.

 

    	2

    	 

    

For illustration purposes
only, if this Warrant entitles the Registered Holder the right to purchase 100,000 shares of Warrant Stock and the Holder were
to exercise this Warrant for 50,000 shares of Warrant Stock at a time when the Exercise Price was reduced to $1.00 and the Fair
Market Value of each share of Preferred Stock was $2.00 on the Exercise Date, as applicable, the cashless exercise calculation
would be as follows:

 

X = 50,000 ($2.00-$1.00)
 $2.00

 

X = 25,000

 

Therefore, the number
of shares of Warrant Stock to be issued to the Holder after giving effect to the cashless exercise would be 25,000 shares of Warrant
Stock and the Company would issue the Holder a new Warrant to purchase 50,000 shares of Warrant Stock, reflecting the portion of
this Warrant not exercised by the Holder. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood
and acknowledged that the Warrant Stock issued in the cashless exercise transaction described pursuant to Section 1(c) shall be
deemed to have been acquired by the Holder, and the holding period for the shares of Warrant Stock shall be deemed to have commenced,
on the date of the Registered Holder’s acquisition of the Warrant.

 

(d) Delivery
to Holder. As soon as practicable after the exercise of this Warrant in whole or in part, and in any event within three
(3) business days thereafter (the “Warrant Stock Delivery Date”), the Company will cause to be issued in the
name of, and delivered to, the Registered Holder, or as such Registered Holder (upon payment by such Registered Holder of any applicable
transfer taxes) may direct:

 

(i)a certificate
or certificates for the number of shares of Warrant Stock to which such Registered Holder shall be entitled, and

 

(ii)in case such
exercise is in part only, a new warrant or warrants of like tenor, calling in the aggregate on the face or faces thereof for the
number of shares of Warrant Stock equal (giving effect to any adjustment therein) to the number of such shares called for on the
face of this Warrant minus the number of such shares surrendered for exercise as provided in Section 1(a).

 

2. Anti-dilution Adjustment.

 

The Registered Holder
shall be entitled to the benefit of all anti-dilution protections contained in the Company’s Restated Certificate of Incorporation,
as amended, and adjustments in the price and number of shares of Common Stock of the Company issuable upon conversion of the Preferred
Stock of the Company for which this Warrant is exercisable which occur prior to the exercise of this Warrant, except in each case,
for such anti-dilution protections or other adjustment to the extent that such protections or adjustments have been waived by the
holders of outstanding Preferred Stock by the requisite vote and/or consent required to waive such protections and adjustments
as to all holders of such Preferred Stock at the time of such waiver. Such anti-dilution protections shall not be restated, amended
or modified in any manner which affects the Holder differently than the holders of preferred stock of the same type as the Preferred
Stock in which this Warrant is convertible, without such Holder’s prior written consent as provided in Section 12.

 

    	3

    	 

    

3.Transfers.

 

(a)Unregistered
Security. The holder of this Warrant acknowledges that this Warrant has not been registered under the Securities Act and
agrees not to sell, pledge, distribute, offer for sale, transfer or otherwise dispose of this Warrant or any Warrant Stock (or
Common Stock) issued upon its exercise in the absence of (i) an effective registration statement under the Securities Act
as to this Warrant or such Warrant Stock and registration or qualification of this Warrant or such Warrant Stock (or Common Stock)
under any applicable U.S. federal or state securities law then in effect or (ii) an opinion of counsel, reasonably satisfactory
to the Company, that such registration and qualification are not required.

 

(b)Transferability.
Subject to the provisions of Section 3(a) hereof, this Warrant and all rights hereunder are transferable, in whole or in part on
and after the Commencement Date; provided, however, subject to the provisions of Section 3(a) hereof, this Warrant and all rights
hereunder are transferable, in whole or in part immediately upon issuance to (i) any entity controlling, controlled by or under
common control of the Registered Holder, or (ii) to any successor, officer, manager or member of the Registered Holder (or to any
officer, manager or member of any successor to the Registered Holder) by surrendering the Warrant with a properly executed assignment
(in the form of Exhibit B hereto) at the principal office of the Company.

 

(c)Warrant
Register. The Company will maintain a register containing the names and addresses of the Registered Holders of this Warrant.
Until any transfer of this Warrant is made in the warrant register, the Company may treat the Registered Holder of this Warrant
as the absolute owner hereof for all purposes. Any Registered Holder may change such Registered Holder’s address as shown
on the warrant register by written notice to the Company requesting such change.

 

4.Registration
Rights. 

 

(a)Provided that
the Common Stock or Preferred Stock underlying the Warrants (the “Registrable Securities”) have not been registered
or are not otherwise freely tradable without restriction pursuant to Rule 144 promulgated under the Securities Act, if at any time
after the Company’s initial public offering under the Securities Act, the Company proposes to register any of its securities
under the Securities Act (other than by a registration in connection with an acquisition in a manner which would not permit registration
of the securities for sale to the public, or a registration on Form S-8 or Form S-4, or any successor forms thereto), then the
Company will at such time give prompt written notice to the Registered Holder of its intention to do so. Upon the written request
or request via electronic mail of the Registered Holder, made within ten (10) days after the receipt of such notice, to include
any of the Registrable Securities in such registration, the Company will, subject to the terms of this Agreement, use its commercially
reasonable best efforts to effect the registration under the Securities Act of the Registrable Securities but in no event later
than 180 days from the date of such request.  The Company shall have the right to terminate or withdraw any registration initiated
by it under this Section 4(a) before the effective date of such registration, whether or not the Registered Holder has elected
to include Registrable Securities in such registration. In connection with any offering involving an underwriting of shares of
the Company’s capital stock pursuant to this Section 4(a), the Company shall not be required to include any of the Registered
Holder’s Registrable Securities in such underwriting unless the Registered Holder accepts the terms of the underwriting as
agreed upon between the Company and its underwriters or if the Registered Holder has not provided the information necessary to
be included in the registration statement.

 

    	4

    	 

    

(b)Commencing one
(1) year after the Company has been subject to the requirements of Section 12 or Section 15(d) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), the Registered Holder is entitled to one “demand” registration right.
Upon receipt of such demand request by the Company from the Registered Holder, the Company shall file a registration statement
on Form S-3 (“Form S-3”) or, if Form S-3 is not available, on any other appropriate form, including Form S-1 and
cause such registration statement to become effected (as defined in Section 4(d)) in an expeditious manner. Furthermore, if at
any time after March 15, 2013 until one (1) year after the Company has been subject to the requirements of Section 12 or Section
15(d) of the Exchange Act, the Company closes on any other financing that grants to other such investors more favorable “demand”
registration rights than granted to the Registered Holder in this Section 4(b), the Registered Holder shall be entitled to such
more favorable “demand” rights granted to such investors.

 

(c)Registration of
Registrable Securities under this Section 4 shall be on such appropriate registration form: (i) as shall be selected by the Company,
and (ii) as shall permit the public disposition of such Registrable Securities in accordance with this Section 4. The Company agrees
to include in any such registration statement all information which the requesting holders of Registrable Securities shall reasonably
request, which is required to be contained therein. The Company will pay all Registration Expenses in connection with each registration
of Registrable Securities pursuant to this Section 4, excluding underwriting discounts and commission, and fees and expenses of
counsel to the Registered Holders.

 

(d)A registration
requested pursuant to this Section 4 shall not be deemed to have been effected: (i) unless a registration statement with respect
thereto has become effective or (ii) if, after it has become effective, such registration is interfered with by any stop order,
injunction or other order or requirement of the Securities and Exchange Commission (the “SEC”) or other governmental
agency or court of competent jurisdiction for any reason, other than by reason of some act or omission by a holder of Registrable
Securities.

 

5.Termination.
This Warrant (and the right to purchase securities upon exercise hereof) shall terminate at 5:00 p.m., Eastern time, on the Expiration
Date.

 

6.Notices
of Certain Transactions. In case:

 

(a)the Company shall
take a record of the holders of its Preferred Stock (or other stock or securities at the time deliverable upon the exercise of
this Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right
to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right, to subscribe
for or purchase any shares of stock of any class or any other securities, or to receive any other right, or

 

(b)of any capital
reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the Company,
any consolidation or merger of the Company with or into another corporation (other than a consolidation or merger in which the
Company is the surviving entity), or any transfer of all or substantially all of the assets of the Company, or

 

(c)of the voluntary
or involuntary dissolution, liquidation or winding-up of the Company,

then, and in each such case, the Company
will mail or cause to be mailed to the Registered Holder of this Warrant a notice specifying, as the case may be, (i) the date
on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character
of such dividend, distribution or right, or (ii) the effective date on which such reorganization, reclassification, consolidation,
merger, transfer, dissolution, liquidation, winding-up is to take place, and the time, if any is to be fixed, as of which the holders
of record of Preferred Stock (or such other stock or securities at the time deliverable upon such reorganization, reclassification,
consolidation, merger, transfer, dissolution, liquidation or winding-up) are to be determined. Failure to send such notice
shall not act to invalidate any such transaction.

    	5

    	 

    

 
 

7.Reservation
of Stock. The Company covenants that at all times it will have authorized, reserve and keep available, solely for the
issuance and delivery upon the exercise of this Warrant, such shares of Warrant Stock and other stock, securities and property,
as from time to time shall be issuable upon the exercise of this Warrant or conversion of the Preferred Stock. The Company covenants
that all Warrant Stock that may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant, be duly authorized, validly issued, fully paid and nonassessable and free
from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue). The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the shares of
Warrant Stock upon the exercise of the purchase rights under this Warrant by the Registered Holder. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Stock may be issued as provided herein without violation
of any applicable law or regulation.

 

8.Replacement
of Warrants. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably
required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of
this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor.

 

9.Notices.
Any notice required or permitted by this Warrant shall be in writing and shall be deemed duly given upon receipt, when delivered
personally or by courier, overnight delivery service, confirmed facsimile or electronic mail, or 48 hours after being deposited
in the regular mail as certified or registered mail (airmail if sent internationally) with postage prepaid, addressed (a) if to
the Registered Holder, to the address of the Registered Holder most recently furnished in writing to the Company and (b) if to
the Company, to the address set forth on the signature page of this Warrant or as subsequently modified by written notice to the
Registered Holder.

 

10.No Rights
as Stockholder. Until the exercise of this Warrant, the Registered Holder of this Warrant shall not have or exercise any
rights by virtue hereof as a stockholder of the Company.

 

11.No Fractional
Shares. No fractional shares of Preferred Stock will be issued in connection with any exercise hereunder. In lieu of any
fractional shares which would otherwise be issuable, the Company shall round the amount of Warrant Stock issuable to the nearest
whole share.

 

12.Consent,
Amendment or Waiver. Any term of this Warrant may be amended or waived upon written consent of the Company and the Registered
Holders of a majority of the Warrant Stock issuable upon the issued and outstanding Warrants.

 

13.Headings.
The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision
of this Warrant.

 

14.Governing
Law. This Warrant and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall
be governed, construed and interpreted in accordance with the laws of the State of New York, without giving effect to principles
of conflicts of law.

 

15.Representations and Warranties
of the Company. This Warrant has been entered into by the Registered Holder in reliance upon the following representations
and covenants of the Company as of the Date of Issuance:

 

(a)Authorization.
The Warrant has been duly executed and delivered by the Company and constitutes a legal, valid and binding obligation of the Company
enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief
of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.

    	6

    	 

    

 

(b)Valid Issuance.
The Warrant Stock is duly authorized and reserved for issuance, and when issued and delivered in accordance with the terms of this
Warrant will be duly and validly issued, fully paid and nonassessable.

 

(c)No Conflict. The
execution and delivery of this Warrant do not, and the consummation of the transactions contemplated hereby will not, conflict
with, or result in any violation of, breach or default (with or without notice or lapse of time, or both), or give rise to a right
of termination, cancellation or acceleration of any obligation or to a loss of a material benefit, under, any provision of the
Restated Certificate of Incorporation or Bylaws of the Company or any order, decree, statute, law, ordinance, rule, listing requirement
or regulation applicable to the Company, its properties or assets, which conflict, violation, default or right would have a material
adverse effect on the business, properties, prospects, financial condition or operations of the Company.

 

16.No Impairment.
The Company will not, by amendment of its Restated Certificate of Incorporation or through reorganization, consolidation, merger,
dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms
of this Warrant, but will (subject to Section 12 above) at all times in good faith assist in the carrying out of all such terms
and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Registered Holder
of this Warrant against impairment.

 

17.Counterparts. This
Warrant may be executed in counterparts, and each such counterpart shall be deemed an original for all purposes.

 

    	7

    	 

    

IN WITNESS WHEREOF, the parties have executed
this Warrant as of the date first above written.

 

EDGE THERAPEUTICS, INC.

 

By: ________________________________

Name: Brian Leuthner

Title: President and Chief Executive Officer

 

 

    	8

    	 

    

(A)            
Exhibit A 

(B)             
WARRANT EXERCISE FORM 

[To be executed only upon exercise of Warrant]

 

To EDGE THERAPEUTICS, INC.:

 

The undersigned registered holder of the within Warrant hereby
irrevocably exercises the Warrant with respect to ________________________ Warrant Shares, at an exercise price per share of $[   
], and requests that the certificates for such Warrant Shares be issued in the name of, and delivered to:

 

______________________________________

______________________________________

______________________________________

______________________________________

 

The undersigned is hereby making payment for the Warrant Shares
in the following manner: [check one]

 

[    ]by cash in accordance with Section 1(a) of the Warrant

 

[    ]via cashless exercise in accordance with Section 1(c)
of the Warrant in the following manner:

 

______________________________________________________________________________

______________________________________________________________________________

______________________________________________________________________________

 

The undersigned hereby represents and warrants that it is, and
has been since its acquisition of the Warrant, the record and beneficial owner of the Warrant.

 

Dated: _______________

 

________________________________________

Print or Type Name

 

________________________________________

(Signature must conform in all respects to name of holder as
specified on the face of Warrant)

 

________________________________________

(Street Address)

 

________________________________________

(City)                              (State)                       (Zip Code)

 

    	 

    	 

    

(C)            
Exhibit B 

(D)            
ASSIGNMENT FORM 

[To be executed only
upon transfer of Warrant]

 

For value received, the undersigned registered holder of the
within Warrant hereby sells, assigns and transfers unto _____________________ [include name and addresses] the rights represented
by the Warrant to purchase __________ shares of Preferred Stock of EDGE THERAPEUTICS, INC. to which the Warrant relates, and appoints
_____________________ Attorney to make such transfer on the books of EDGE THERAPEUTICS, INC. maintained for the purpose, with full
power of substitution in the premises.

 

	Dated:	________________________________________
	                 	(Signature must conform in all respects 
	                                 	to name of holder as specified on the
	                                 	face of Warrant)
	 	 
	                                 	________________________________________
	                                 	(Street Address)
	 	 
	                                 	________________________________________
	                                 	(City)        (State)      (Zip Code)
	 	 
	 	 
	 	Signed in the presence of:
	 	 
	 	 
	 	 
	                                 	________________________________________
	                                 	(Signature of Transferee)
	 	 
	                                 	________________________________________
	                                 	(Street Address)
	 	 
	                                 	________________________________________
	                                 	(City)        (State)      (Zip Code)

 

Signed in the presence of:Exhibit 10.2

 

EDGE THERAPEUTICS, INC.

2010 EQUITY INCENTIVE PLAN

 

Section 1.Purpose; Definitions. The
purposes of the Edge Therapeutics, Inc. 2010 Equity Incentive Plan (the “Plan”) are to: (a) enable
Edge Therapeutics, Inc. (the “Corporation”) and its respective affiliated companies to recruit and
retain highly qualified personnel; (b) provide those employees, directors and consultants of the Corporation with an
incentive for productivity; and (c) provide those personnel with an opportunity to share in the growth and value of the
Corporation.

 

For
purposes of the Plan, the following capitalized words and phrases will be defined as set forth below, unless the context clearly
requires a different meaning:

 

(a)               
“Affiliate” means, with respect to a Person, a Person that directly or indirectly
controls, or is controlled by, or is under common control with such Person.

 

(b)              
“Award” means a grant of Options or Restricted Stock pursuant to the provisions
of the Plan.

 

(c)               
“Award Agreement” means, with respect to any particular Award, the written
document that sets forth the terms of that particular Award.

 

(d)              
“Board” means the Board of Directors of the Corporation, as constituted from
time to time; provided, however, that if the Board appoints a Committee to perform some or all of the Board's administrative functions
hereunder pursuant to Section 2, references in the Plan to the “Board” will be deemed to also refer to that
Committee in connection with matters to be performed by that Committee.

 

(e)               
“Cause” means (i) conviction of, or the entry of a plea of guilty or no contest to, a 
felony or any other crime that causes the Corporation or its Affiliates public disgrace
or disrepute, or adversely affects the Corporation's or its Affiliates' operations or financial performance or the relationship
the Corporation has with its Affiliates; (ii) gross negligence or willful misconduct with respect to the Corporation or any of
its Affiliates, including, without limitation, fraud, embezzlement, theft or proven dishonesty in the course of the subject employment
or engagement with the Corporation or its Affiliates; (iii) alcohol abuse or use of controlled drugs other than in accordance with
a physician's prescription; (iv) refusal, failure or inability to perform any material obligation or fulfill any duty (other than
any duty or obligation of the type described in clause (vi) below) to the Corporation (other than due to a Disability), which failure,
refusal or inability is not cured within 30 days after delivery of notice thereof; (v) material breach of any agreement with or
duty owed to the Corporation or any of its Affiliates; or (vi) any breach of any obligation or duty to the Corporation or any of
its Affiliates (whether arising by statute, common law, contract or otherwise) relating to confidentiality, noncompetition, nonsolicitation
or proprietary rights. Notwithstanding the foregoing, if a Participant and the Corporation (or any of its Affiliates) have entered
into an employment agreement, consulting agreement or other similar agreement that specifically defines “cause,”
then with respect to such Participant, “Cause” shall have the meaning
defined in that employment agreement, consulting agreement or other agreement.

 

    	1

    	 

    

(f)               
 “Change of Control” means, with respect to any entity and except for the sole purpose of changing
domicile: (i) the sale, transfer, assignment or other disposition (including by merger or consolidation, but excluding any sales
by stockholders or other equity holders made as part of an underwritten public offering of the common stock of the entity) by stockholders
of the entity, in one transaction or a series of related transactions, of more than 50% of the voting power represented by the
then outstanding capital stock or other equity interests of the entity to one or more Persons, (ii) the sale of all or substantially
all the assets of the entity (other than a transfer of financial assets made in the ordinary course of business for the purpose
of securitization), or (iii) the liquidation or dissolution of the entity.

 

(g)              
“Code” means the Internal Revenue Code of 1986, as amended from time to time, and any successor
thereto.

 

(h)              
“Committee” means a committee appointed by the Board in accordance with Section 2 of the
Plan.

 

(i)                
“Director” means a member of the Board.

 

(j)                
“Disability” means a condition rendering a Participant Disabled.

 

(k)              
“Disabled” will have the same meaning as set forth in Section 22(e)(3) of the Code.

 

(l)                
“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

(m)            
“Fair Market Value” means, with respect to a Share, as of any date: (i) in the case of any determination
thereof other than in connection with a Change of Control, (x) if the Shares are not publicly traded, the value of such Shares
on that date, as determined by the Board after using a valuation method that complies with regulations for determining fair market
value as promulgated by the Internal Revenue Service; or (y) if the Shares are publicly traded, the last sale price of a Share
on the trading day immediately prior to the date of determination of fair market value or, if no sale is publicly reported on such
trading day, the last sale price of a Share prior to the date of determination of fair market value; and (ii) in the case of any
determination thereof in connection with a Change of Control, the value of a Share attributable to such Shares in the transaction
giving rise to the such Change of Control or, if no such value is so attributable, the value as determined by the Board after using
a valuation method that complies with regulations for determining fair market value as promulgated by the Internal Revenue Service.

 

(n)              
“Incentive Stock Option” means any Option intended to be and designated as an “Incentive
Stock Option” within the meaning of Section 422 of the Code.

 

(o)              
“Non-Employee Director” will have the meaning set forth in Rule 16b-3(b)(3)(i) promulgated by
the Securities and Exchange Commission under the Exchange Act, or any successor definition adopted by the Securities and Exchange
Commission; provided, however, that the Board or the Committee may, to the extent that it deems necessary to comply with Section
162(m) of the Code or regulations thereunder, require that each “Non-Employee Director” also be an “outside director”
as that term is defined in regulations under Section 162(m).

 

    	2

    	 

    

(p)              
“Non-Qualified Stock Option” means any Option that is not an Incentive Stock Option.

 

(q)              
“Option” means any option to purchase Shares (including Restricted Stock, if the Board so determines) granted pursuant to Section 5 hereof.

 

(r)                
“Participant” means an employee, consultant, Director, or other service provider
of or to the Corporation or any of its respective Affiliates to whom an Award is granted.

 

(s)               
“Person” or “Persons” means an individual(s), partnership(s), corporation(s),
limited liability company(ies), trust(s), joint venture(s), unincorporated association(s), or other entity(ies) or association(s).

 

(t)                
“Restricted Stock” means Shares that are subject to restrictions pursuant to
Section 7 hereof.

 

(u)              
“Shares” means shares of the
Corporation's common stock, $0.001 par value per
share, subject to substitution or adjustment as provided in Section 3(c) hereof.

 

(v)              
“Stockholders’ Agreement” means any Stockholders' Agreement, Voting
Agreement, Right of First Refusal and Co-Sale Agreement or other similar agreement to be executed and delivered by a Participant
at the time of any event of an Award or upon the exercise of any Options subject to an Award, as determined by the Board, and in
such form from time to time prescribed by the Board, as amended from time to time.

 

(w)            
“Subsidiary” means, with respect to the Corporation, a subsidiary corporation,
whether now or hereafter existing, as defined in Sections 424(f) and (g) of the Code.

 

Section
2.Administration. The Plan will be administered by the Board; provided, however, that the Board may at any time
appoint a Committee to perform some or all of the Board's administrative functions hereunder; provided further, that the
authority of any Committee appointed pursuant to this Section 2 will be subject to such terms and conditions as the
Board may prescribe and will be coextensive with, and not in lieu of, the authority of the Board hereunder.

 

Subject
to the requirements of the Corporation's Bylaws (as the same may be amended and/or restated from time to time), Certificate of
Incorporation (as the same may be amended and/or restated from time to time) and/or any other agreement that governs the appointment
of Board committees, any Committee established under this Section 2 will be composed of not fewer than 2 members, each of
whom will serve for such period of time as the Board determines; provided, however, that if the Corporation has a class of securities
required to be registered under Section 12 of the Exchange Act, all members of any Committee established pursuant to this Section
2 will be Non-Employee Directors. From time to time the Board may increase the size of the Committee and appoint additional
members thereto, remove members (with or without cause) and appoint new members in substitution therefor, fill vacancies however
caused, or remove all members of the Committee and thereafter directly administer the Plan.

 

    	3

    	 

    

Directors
who are eligible for Awards or have received Awards may vote on any matters affecting the administration of the Plan or the grant
of Awards, except that no such member will act upon the grant of an Award to himself or herself, but any such member may be counted
in determining the existence of a quorum at any meeting of the Board during which action is taken with respect to the grant of
Awards to himself or herself.

 

The
Board will have full authority to grant Awards under this Plan. In particular, subject to the terms of the Plan, the Board will
have the authority:

 

(a)               
to select the Persons to whom Awards may from time to time be granted hereunder (consistent with the eligibility conditions
set forth in Section 4);

 

(b)              
to determine the type of Award to be granted to any Person hereunder;

 

(c)               
to determine the number and type of Shares, if any, to be covered by each Award (consistent with the provisions of Section
3 regarding the maximum number of Shares subject to the Plan);

 

(d)              
to establish the terms and conditions of each Award Agreement;

 

(e)               
to determine whether and under what circumstances an Option may be exercised without a payment of cash under Section
5(d); and

 

(f)               
to require execution of a Stockholders' Agreement which may include, among other things, restrictions on resale of Shares
and/or a requirement to sell Shares in connection with a Change of Control or other similar transactions, and may impose a limitation
on marketability in connection with a public offering of the Corporation's stock.

 

The
Board will have the authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan
as it, from time to time, deems advisable; to establish the terms of each Award Agreement; to interpret the terms and provisions
of the Plan and any Award issued under the Plan (and any Award Agreement); and to otherwise supervise the administration of the
Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any Award in the manner
and to the extent it deems necessary to carry out the intent of the Plan.

 

All
decisions made by the Board pursuant to the provisions of the Plan will be final and binding on all Persons, including the Corporation
and Participants. No Director will be liable for any good faith determination, act or omission in connection with the Plan or any
Award.

    	4

    	 

    

 

  

Section 3.Shares Subject to
the Plan.

 

(a)               
Shares Subject to the Plan. The Shares to be subject to Options or Restricted
Stock under the Plan will be authorized and unissued Shares of the Corporation, whether or not previously issued and subsequently
acquired by the Corporation. The maximum number of Shares that may be subject to Options or Restricted Stock under the Plan is
250,000. The Corporation will reserve for the purposes of the Plan, out of its authorized and unissued Shares, such number of Shares.

 

(b)              
Effect of the Expiration or Termination of Awards. If and to the extent that an
Option expires, terminates or is canceled or forfeited for any reason without having been exercised in full, the Shares associated
with that Option will again become available for grant under the Plan. Similarly, if any Restricted Share is canceled, forfeited
or repurchased for any reason, or if any Share is withheld pursuant to Section 9(d) in settlement of a tax withholding obligation
associated with an Award, that Share will again become available for grant under the Plan. If any Share is received in satisfaction
of the exercise price payable upon exercise of an Option, that Share will become available for grant under the Plan.

 

(c)               
Other Adjustment.In the event of any recapitalization, stock split or
combination, stock dividend or other similar event or transaction affecting the Shares, equitable substitutions or adjustments
may be made by the Board, in its sole and absolute discretion, to (i) the aggregate number, type and issuer of the securities reserved
for issuance under the Plan, (ii) the number, type and issuer of Shares subject to outstanding Options, (iii) the exercise price
of outstanding Options, and (iv) the number, type and issuer of Restricted Stock.

 

(d)              
Change of Control. Notwithstanding anything to the contrary set forth in the
Plan, upon or in anticipation of any Change of Control of the Corporation or any of its Affiliates, the Board, as constituted prior
to such Change of Control, may, in its sole and absolute discretion and without the need for the consent of any Participant, take
one or more of the following actions contingent upon the occurrence of that Change of Control: (i) cause any or all outstanding
Options to become vested and immediately exercisable, in whole or in part; (ii) cause any or all outstanding Restricted Stock to
become non-forfeitable, in whole or in part; (iii) cancel any Option in exchange for an option to purchase common stock of any
successor corporation or its parent in a manner consistent with the requirements of Treas. Reg. § 1.424-1 (a)(4)(i) (notwithstanding
the fact that the original Option may never have been intended to satisfy the requirements for treatment as an Incentive Stock
Option); (iv) cancel any Restricted Stock in exchange for restricted shares of the common stock of any successor corporation; (v)
redeem any Restricted Stock for cash and/or other substitute consideration with a value equal to the Fair Market Value of an unrestricted
Share on the date of the Change of Control; or (vi) cancel any Option held by a Participant affected by the Change of Control in
exchange for cash and/or other substitute consideration with a value equal to (A) the number of Shares subject to that Option,
multiplied by (B) the difference, if any, between the Fair Market Value per Share on the date of the Change of Control and the
exercise price of that Option; provided, however, that if the Fair Market Value per Share on the date of the Change of Control
does not exceed the exercise price of any such Option, the Board may cancel that Option without any payment of consideration therefor.

 

    	5

    	 

    

For
purposes of clause (d)(iii) in this Section 3, the exchange of an Option issued under the Plan for an option to purchase
common stock of any successor corporation or its parent shall be permitted only to the extent that the ratio of the exercise price
to the fair market value of the shares subject to the Option immediately after the substitution or assumption is not greater than
the ratio of the exercise price to the Fair Market Value of the Shares subject to the Option immediately before the substitution
or assumption.

 

Section
4.Eligibility. Employees, Directors, consultants, and other individuals who provide services to the Corporation or
its Affiliates are eligible to be granted Awards under the Plan. Persons who are not employees of the Corporation or a
Subsidiary are not eligible to be granted Incentive Stock Options but are eligible to be granted other types of Awards.

 

Section 5.Options. Options granted
under the Plan may be of two types: (i) Incentive Stock Options, or (ii) Non-Qualified Stock Options. Any Option granted
under the Plan will be in such form as the Board may at the time of such grant approve. Without limiting the generality of Section
3(a), any number of the maximum number of Shares provided for in Section 3(a) may be subject to Incentive Stock
Options or Non-Qualified Stock Options, or any combination thereof.

 

The
Award Agreement evidencing any Option will incorporate the following terms and conditions and will contain such additional terms
and conditions, not inconsistent with the terms of the Plan, as the Board deems appropriate in its sole and absolute discretion:

 

(a)               
Option Price. The exercise price per Share purchasable under an Incentive Stock
Option or a Non-Qualified Stock Option will be not less than 100% of the Fair Market Value of the Share on the date of the grant.
However, any Incentive Stock Option granted to any Participant who, at the time the Option is granted, owns more than 10% of the
voting power of all classes of shares of the Corporation or of a Subsidiary will have an exercise price per Share of not less than
110% of Fair Market Value per Share on the date of the grant.

 

(b)              
Option Term. The term of each Option will be fixed by the Board, but no
Incentive Stock Option will be exercisable more than 10 years after the date the Option is granted. However, any Incentive Stock
Option granted to any Participant who, at the time such Option is granted, owns more than 10% of the voting power of all classes
of shares of the Corporation or of a Subsidiary may not have a term of more than 5 years. No Option may be exercised by any Person
after expiration of the term of the Option.

 

(c)               
Exercisability. Options will vest and be exercisable at such time or times and
subject to such terms and conditions as determined by the Board at the time of grant. If the Board provides, in its sole and absolute
discretion, that any Option is exercisable only in installments, the Board may waive such installment exercise provisions at any
time at or after grant, in whole or in part, based on such factors as the Board determines, in its sole and absolute discretion.

 

    	6

    	 

    

(d)              
Method of Exercise. Subject to the exercisability provisions of Section 5(c) and
the termination provisions set forth in Section 6, Options may be exercised in whole or in part at any time and from time
to time during the term of the Option, by the delivery of written notice of exercise by the Participant to the Corporation specifying
the number of Shares to be purchased. Such notice will be accompanied by payment in full of the purchase price, either by cash
or certified or bank check, or such other means as the Board may accept in its sole discretion. As determined by the Board, in
its sole and absolute discretion, at or after grant, payment in full or in part of the exercise price of an Option may be made
in the form of previously acquired Shares based on the Fair Market Value of the Shares on the date the Option is exercised; provided,
however, that, in the case of an Incentive Stock Option, the right to make a payment in the form of previously acquired Shares
may be authorized only at the time the Option is granted.

 

No
Shares will be issued upon exercise of an Option until full payment therefor has been made. A Participant will not have the right
to distributions or dividends or any other rights of a stockholder with respect to Shares subject to the Option until the Participant
has given written notice of exercise, has paid in full for such Shares, and, if requested, has given the representation described
in Section 9(a) hereof.

 

(e)               
Incentive Stock Option Limitations. In the case of an Incentive Stock Option, the
aggregate Fair Market Value (determined as of the time of grant) of the Shares with respect to which Incentive Stock Options are
exercisable for the first time by the Participant during any calendar year under the Plan and/or any other plan of the Corporation
or any Subsidiary will not exceed $100,000. For purposes of applying the foregoing limitation, Incentive Stock Options will be
taken into account in the order granted. To the extent any Option does not meet such limitation, that Option will be treated for
all purposes as a Non-Qualified Stock Option.

 

(f)               
Termination of Service. Unless otherwise specified in the Award Agreement,
Options will be subject to the terms of Section 6 with respect to exercise upon or following termination of employment or
other service.

 

(g)              
Transferability of Options. Except as may otherwise be specifically determined
by the Board with respect to a particular Option, no Option will be transferable by the Participant other than by will or by the
laws of descent and distribution, and all Options will be exercisable, during the Participant's lifetime, only by the Participant
or, in the event of his or her Disability, by his or her personal representative.

 

Section
6.Termination of Service. Unless otherwise specified with respect to a particular Option in the applicable Award
Agreement, all Options will remain exercisable after termination of employment only to the extent specified in this Section
6.

 

(a)              
Termination by Reason of Death.
If a Participant's service with the Corporation or any Affiliate terminates by reason of death, any Option held by such
Participant may thereafter be exercised, to the extent then exercisable or on such accelerated basis as the Board may
determine, at or after grant, by the legal representative of the estate or by the legatee of the Participant under the will
of the Participant, for a period expiring on the earliest to occur of (i) such time as may be specified by the Board at or
after the time of grant, or (ii) if not specified by the Board, then 12 months from the date of death, or (iii) the
expiration of the stated term of such Option.

 

    	7

    	 

    

(b)              
Termination by Reason of Disability. If a Participant's service with the
Corporation or any Affiliate terminates by reason of Disability, any Option held by such Participant may thereafter be exercised
by the Participant or his or her personal representative, to the extent it was exercisable at the time of termination, or on such
accelerated basis as the Board may determine at or after grant, for a period expiring on the earliest to occur of (i) such time
as may be specified by the Board at or after the time of grant, or (ii) if not specified by the Board, then 12 months from the
date of termination of service, or (iii) the expiration of the stated term of such Option.

 

(c)               
Cause. If a Participant's service with the Corporation or any Affiliate is
terminated for Cause: (i) any Option not already exercised will be immediately and automatically forfeited as of the date of such
termination, and (ii) any Shares for which the Corporation has not yet delivered share certificates will be immediately and automatically
forfeited and the Corporation will refund to the Participant the Option exercise price paid for such Shares, if any.

 

(d)              
Other Termination. If a Participant's service with the Corporation or any Affiliate
terminates for any reason other than death, Disability or Cause, then, except as otherwise provided in the applicable Award Agreement,
any Option held by such Participant may thereafter be exercised by the Participant, to the extent it was exercisable at the time
of such termination, or on such accelerated basis as the Board may determine at or after grant, for a period expiring on the earliest
to occur of (i) such time as may be specified by the Board at or after the time of grant, or (ii) if not specified by the Board,
then 90 days from the date of termination of service, or (iii) the expiration of the stated term of such Option.

 

Section 7.Restricted Stock.

 

(a)               
Issuance. Restricted Stock may be issued either alone or in conjunction with
other Awards. The Board will determine the time or times within which Restricted Stock may be subject to forfeiture, and all other
conditions of such Awards.

 

(b)              
Awards and Certificates. The Award Agreement evidencing the grant of any
Restricted Stock will contain such terms and conditions, not inconsistent with the terms of the Plan, as the Board deems appropriate
in its sole and absolute discretion. The prospective recipient of an Award of Restricted Stock will not have any rights with respect
to such Award, unless and until such recipient has delivered to the Corporation an executed Award Agreement and has otherwise complied
with the applicable terms and conditions of such Award. The purchase price for Restricted Stock may, but need not, be zero.

 

A share
certificate will be issued in connection with each Award of Restricted Stock. Such certificate will be registered in the name of
the Participant receiving the Award, and will bear the following legend and/or any other legend required by (i) this Plan, the
Award Agreement, a Stockholders' Agreement, or any other agreement governing the issuance of such Award of Restricted Stock, or
(ii) by applicable law:

    	8

    	 

    

 

 

THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE PLEDGED, HYPOTHECATED, SOLD OR TRANSFERRED
IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION
OF COUNSEL SATISFACTORY TO THE CORPORATION THAT SUCH PLEDGE, HYPOTHECATION, SALE OR TRANSFER IS EXEMPT THEREFROM UNDER THE SECURITIES
ACT AND APPLICABLE STATE SECURITIES LAWS.

 

THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER, REPURCHASE RIGHTS, AND/OR FORFEITURE CONDITIONS AS SET FORTH
IN THE EDGE THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN, A RESTRICTED STOCK AWARD AGREEMENT, AND/OR A STOCKHOLDERS' (OR SIMILAR)
AGREEMENT(S), COPIES OF WHICH ARE ON FILE AT THE PRINCIPAL OFFICE OF THE CORPORATION AND WILL BE FURNISHED UPON REQUEST TO THE
HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.

 

Share
certificates evidencing Restricted Stock will be held in custody by the Corporation or in escrow by an escrow agent until the restrictions
thereon have lapsed. As a condition to any Restricted Stock Award, the Participant may be required to deliver to the Corporation
a stock power, endorsed in blank, relating to the Shares covered by such Award.

 

(c)               
Restrictions and
Conditions. The Restricted Stock awarded pursuant to this Section 7 will be subject to the following restrictions
and conditions, and any other restrictions and conditions set forth in the Award Agreement:

 

(i)                
During a period commencing with the date of an Award of
Restricted Stock and ending at such time or times as specified by the Board (the “Restriction Period ”),
the Participant will not be permitted to sell, transfer, pledge, assign or otherwise encumber Restricted Stock awarded under the
Plan. The Board may condition the lapse of restrictions on Restricted Stock upon the continued employment or service of the recipient,
the attainment of specified individual or corporate performance goals, or such other factors as the Board may determine, in its
sole and absolute discretion.

 

(ii)               Except
as provided in this Paragraph (ii) or Section 7(c)(i), once the Participant has been issued a certificate or
certificates for Restricted Stock, the Participant will have, with respect to the Restricted Stock, all of the rights of a
stockholder of the Corporation, including the right to vote the Shares, and the right to receive any cash distributions or
dividends. Any distributions or dividends paid in the form of securities with respect to Restricted Stock will be subject to
the same terms and conditions as the Restricted Stock with respect to which they were paid, including, without limitation,
the same Restriction Period.

 

    	9

    	 

    

(iii)            
Subject to the applicable provisions of the Award Agreement, if a
Participant's service with the Corporation and its Affiliates terminates prior to the expiration of the Restriction Period, all
of that Participant's Restricted Stock which then remain subject to forfeiture will then be forfeited automatically.

 

(iv)            
If and when the Restriction Period expires without a prior
forfeiture of the Restricted Stock subject to such Restriction Period (or if and when the restrictions applicable to Restricted
Stock lapse pursuant to Section 3(d) hereof), the certificates for such Shares will be replaced with new certificates, without
the restrictive legends described in Section 7(b) hereof applicable to such lapsed restrictions, and such new certificates
will be promptly delivered to the Participant, the Participant's representative (if the Participant has suffered a Disability),
or the Participant's estate or heir (if the Participant has died).

 

Section 8.Amendments and Termination.
The Board may amend, alter or

 

discontinue the Plan at
any time, but except as otherwise provided in Section 3(d) of the Plan, no amendment, alteration or discontinuation will
be made which (i) would impair the rights of a Participant with respect to an Award, without that Participant's consent, or (ii)
would (a) increase the total number of Shares reserved for the purposes of the Plan (except as otherwise provided in Section
3(c) hereof), or (b) change the Persons or class of Persons eligible to receive Awards, without the approval by the stockholders
of the Corporation within 365 days of the date on which such amendment is adopted by the Board in a manner consistent with Section
1.422-5 of the Treasury Regulations.

 

Section 9.General Provisions.

 

(a)               
The Board may require each Participant to represent to and agree with the
Corporation in writing that the Participant is acquiring securities of the Corporation for investment purposes and without a view
to distribution thereof and as to such other matters as the Board believes are appropriate. The certificate evidencing any Award
and any securities issued pursuant thereto may include any legend which the Board deems appropriate to reflect any restrictions
on transfer and compliance with applicable securities laws.

 

(b)              
All certificates for Shares or other securities delivered under the Plan will be
subject to such share-transfer orders and other restrictions as the Board may deem advisable under the rules, regulations, and
other requirements of the Securities Act of 1933, as amended, the Exchange Act, any stock exchange upon which the Shares are then
listed, and any other applicable federal or state securities laws, and the Board may cause a legend or legends to be put on any
such certificates to make appropriate reference to such restrictions.

 

    	10

    	 

    

(c)               
Nothing contained in the Plan will prevent the Board from adopting other or
additional compensation arrangements, subject to stockholder approval if such approval is required, and such arrangements may be
either generally applicable or applicable only in specific cases.

 

(d)              
Neither the adoption of the Plan nor the execution of any document in connection
with the Plan will (i) confer upon any employee of the Corporation or an Affiliate any right to continued employment or engagement
with the Corporation or such Affiliate, or (ii) interfere in any way with the right of the Corporation or such Affiliate to terminate
the employment of any of its employees at any time.

 

(e)               
No later than the date as of which an amount first becomes includible in the gross
income of the Participant for federal income tax purposes with respect to any Award under the Plan, the Participant will pay to
the Corporation, or make arrangements satisfactory to the Board regarding the payment of, any federal, state or local taxes of
any kind required by law to be withheld with respect to such amount. Unless otherwise determined by the Board, the minimum required
withholding obligations may be settled with Shares, including, without limitation, Shares that are part of the Award that gives
rise to the withholding requirement. However, any required withholding obligations may not be settled with Shares of Restricted
Stock awarded under this Plan. The obligations of the Corporation under the Plan will be conditioned on such payment or arrangements
and the Corporation will, to the extent permitted by law, have the right to deduct any such Social Security contribution and taxes
from any payment of any kind otherwise due to the Participant.

 

Section
10. Effective Date of Plan. Subject to the approval of the Plan by the Corporation's stockholders within 12 months of the
Plan's adoption by the Board, the Plan will become effective on the date that it is adopted by the Board.

 

Section 11.Term of
Plan. The Plan will continue in effect until terminated in accordance with Section 8 hereof; provided, however,
that no Incentive Stock Option will be granted hereunder on or after the 10th anniversary of the date of stockholder approval
of the Plan (or, if the stockholders approve an amendment that increases the number of Shares subject to the Plan, the 10th
anniversary of the date of such approval); provided further, that Incentive Stock Options granted prior to such 10th
anniversary may extend beyond such date.

 

Section 12.Invalid Provisions. In
the event that any provision of this Plan is found to be invalid or otherwise unenforceable under any applicable law, such
invalidity or unenforceability will not be construed as rendering any other provisions contained herein as invalid or
unenforceable, and all such other provisions will be given full force and effect to the same extent as though the invalid or
unenforceable provision was not contained herein.

 

Section
13. Governing Law. The Plan and all Awards granted hereunder will be governed by and construed in accordance with the laws
and judicial decisions of the State of Delaware, without regard to the application of the principles of conflicts of laws of Delaware
or any other jurisdiction.

 

    	11

    	 

    

Section
14. Board Action. Notwithstanding anything to the contrary set forth in the Plan, any and all actions of the Board or Committee,
as the case may be, taken under or in connection with the Plan and any agreements, instruments, documents, certificates or other
writings entered into, executed, granted, issued and/or delivered pursuant to the terms hereof, will be subject to and limited
by any and all votes, consents, approvals, waivers or other actions of all or certain stockholders of the Corporation or other
Persons required by:

 

(a)               
the Corporation's Certificate of Incorporation (as the same may be amended
and/or restated from time to time);

 

(b)              
the Corporation's Bylaws (as the same may be amended and/or restated from time
to time); and

 

(c)               
any other agreement, instrument, document or writing now or hereafter existing,
between or among the Corporation and its stockholders or other Persons (as the same may be amended from time to time).

 

Section
15. Notices. Any notice to be given to the Corporation pursuant to the provisions of the Plan shall be given by registered
or certified mail, postage prepaid, and, addressed, if to the Corporation to its principal executive office to the attention of
its President or Chief Executive Officer (or such other Person as the Corporation may designate in writing from time to time),
and, if to a Participant, to the address given beneath his or her signature on his or her Award Agreement, or at such other address
as such Participant may hereafter designate in writing to the Corporation. Any such notice shall be deemed given or delivered 3
days after the date of mailing.

 

ADOPTION
AND APPROVAL OF PLAN

 

Date Plan adopted by Board: May 11, 2010 Date

 

Plan approved by Stockholders: May 11, 2010

 

 

 

 

    	12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}]]